Assessment of the Risk of Transfusion-Transmitted Viral Infections
- 1 June 2003
- journal article
- Published by Wiley in Transfusion Alternatives in Transfusion Medicine
- Vol. 5 (2) , 319-325
- https://doi.org/10.1111/j.1778-428x.2003.tb00169.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Risks associated with transfusion of cellular blood components in canadaTransfusion Medicine Reviews, 2003
- Persistence of HTLV-I in blood components after leukocyte depletionBlood, 2002
- HBV: amplified and back in the blood safety spotlightTransfusion, 2001
- NAT of the United States and Canadian blood supplyTransfusion, 2000
- Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of bloodBMJ, 2000
- Evidence that anti‐HBc but not HBV DNA testing may prevent some HBV transmission by transfusionBritish Journal of Haematology, 1999
- The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infectionTransfusion Medicine Reviews, 1997
- A method for estimating hepatitis B virus incidence rates in volunteer blood donors. National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor StudyTransfusion, 1997
- The Risk of Transfusion-Transmitted Viral InfectionsNew England Journal of Medicine, 1996
- Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection.BMJ, 1993